Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1

A Bhatta, L Yao, Z Xu, HA Toque, J Chen… - Cardiovascular …, 2017 - academic.oup.com
Aims Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …

[HTML][HTML] Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1

A Bhatta, L Yao, Z Xu, HA Toque, J Chen… - Cardiovascular …, 2017 - ncbi.nlm.nih.gov
Aims Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …

[引用][C] Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1

A Bhatta, L Yao, Z Xu, HA Toque, J Chen… - Cardiovascular …, 2017 - cir.nii.ac.jp
Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase
1 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …

[PDF][PDF] Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase

A Bhatta, L Yao, Z Xu, HA Toque, J Chen, RT Atawia… - academia.edu
Aims Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …

Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.

A Bhatta, L Yao, Z Xu, HA Toque… - Cardiovascular …, 2017 - search.ebscohost.com
Aims Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …

Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1

A Bhatta, L Yao, Z Xu, HA Toque, J Chen… - Cardiovascular …, 2017 - academic.oup.com
Aims Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …

Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.

A Bhatta, L Yao, Z Xu, HA Toque, J Chen… - Cardiovascular …, 2017 - europepmc.org
Aims Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …

Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1

A Bhatta, L Yao, Z Xu, HA Toque… - Cardiovascular …, 2017 - pubmed.ncbi.nlm.nih.gov
Aims Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …

Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.

A Bhatta, YL Yao Lin, XZM Xu ZhiMin, HA Toque… - 2017 - cabidigitallibrary.org
Aims: Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …

Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1

A Bhatta, L Yao, Z Xu, HA Toque… - Cardiovascular …, 2017 - augusta.elsevierpure.com
Aims Elevation of arginase activity has been linked to vascular dysfunction in diabetes and
hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L …